Loading clinical trials...
Loading clinical trials...
Over the last few years, dysbiosis has emerged as a possible trigger of gut inflammation in inflammatory bowel disease (IBD) and a promising therapeutic target. The complex diversity of microbiota was...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Hospices Civils de Lyon
NCT04844606 · Ulcerative Colitis, Ulcerative Colitis Chronic, and more
NCT06553053 · Crohn's Disease Relapse, Inflammatory Bowel Diseases
NCT06226883 · Inflammatory Bowel Diseases, Crohn's Disease
NCT05986136 · Inflammatory Bowel Diseases
NCT06266663 · Inflammatory Bowel Diseases
Service de gastroentérologie nutrition, hépatologie pédiatrique - Hôpital Femme Mère Enfant groupement hospitalier Est - HCL
Bron
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions